The biotechnology industry is still a growth industry. Investing in an ETF gives me exposure to an industry I don't fully understand. The two major ETFs in the industry have different portfolio ...

In the world of biotechnology investing, companies often struggle to bring new drugs to market. Developing treatments for rare diseases can be incredibly expensive, and because these conditions affect ...

Within Utah’s booming tech sector, the state’s rapidly evolving biotechnology industry is being turbocharged by projects like Tech Lake City and BioHive. These initiatives are helping companies that ...

The Biocon board cleared the issuance of 17.1 crore new shares to Biocon Biologics’ minority shareholders at Rs 405.6 per ...

NBMA advocates safe biotechnology for environmental sustainability ‎ ‎He, however, noted that Nigeria is yet to fully benefit ...

One fast-rising biotech is gearing up for pivotal trials just as a major specialist fund walks away—here’s what long-term ...

Biocon plans to merge Biocon Biologics, acquiring remaining stakes for $5.5 billion, enhancing its global biosimilars and ...

Two new reports paint the most detailed portraits yet of the increasing globalization of the biotech industry and the growing competition between U.S. metropolitan areas to become centers of ...

BRUSSELS, May 15, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology, a global leader in in-vitro diagnostic (IVD) technologies, is pleased to announce its participation in three major international ...

Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for ...

BRUSSELS, May 15, 2025 /PRNewswire/ -- Anbio Biotechnology, a global leader in in-vitro diagnostic (IVD) technologies, is pleased to announce its participation in three major international exhibitions ...